Catalyst Wire Dossier Catalyst Wire Dossier

ELUVIA

Everolimus-eluting stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELUVIA, covering 2019-01-07 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery [NA]

See pricing